Herclon is indicated in combination with cisplatin and either capecitabine or 5-FU for the treatment of patients with HER2 positive advanced adenocarcinoma of the stomach or gastro-oesophageal junction who have not received prior anti-cancer treatment for their metastatic disease.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Herclon (trastuzumab) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Lynparza (olaparib) tablets cost price in India.
The order for Herclon (trastuzumab) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Trastuzumab tablets and capsules are also used to treat ovarian cancer in people with a specific gene who have not improved or who have worsened after treatment with at least three other therapies. Trastuzumab is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme inhibitor. It works by killing cancer cells..
Generic Name: Trastuzumab
Herclon 150 mg single-dose vials: each pack contains one vial of Herclon (150 mg trastuzumab).
Herclon 440 mg multi-dose vials: each pack contains one vial of Herclon (440 mg trastuzumab) and one 20 mL vial of Bacteriostatic Water for Injection.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Herclon (trastuzumab) on prescription and Import License in Patient's Name only.
For overseas patients, Herclon (trastuzumab) can be made available in Send your enquiry to find Herclon (trastuzumab) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Herclon (trastuzumab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
US FDA panel nod for Biocon breast cancer biosimilar For More Details
Global Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight 2016: One of Roche's Three Her2+ Breast Cancer Drugs, Recorded a 15% Sales Increase in the US and a 10% Rise Overall - Research and MarketsReadMore